Contact this trialFirst, we need to learn more about you.
Antimetabolite
Pembrolizumab + Standard Care for Rectal Cancer
Recruiting1 awardPhase 1
Cleveland, Ohio
This trial is testing an investigational drug called Pembrolizumab in combination with the standard of care (SOC) for locally advanced rectal cancer, which includes neoadjuvant chemotherapy and radiation followed by surgery. Mismatch repair deficient locally advanced rectal cancer is a type of cancer that is difficult to treat because patients often do not respond well to the SOC. The purpose of this study is to see if Pembrolizumab can improve treatment outcomes for these patients.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.